Artrya
Follow
Get notifications in MyBN when activity occurs.
Artrya is an applied artificial intelligence healthcare company that is working to improve the diagnosis of heart disease.
It develops artificial intelligence tools for clinicians to improve the diagnosis of coronary heart disease, and to predict and prevent acute coronary events.
Artrya listed on the ASX on 26 November 2021.
Lists and Charts
Public Companies - Industrial WA list sponsored by
Technology Companies list sponsored by
Share price
Closing price for the last 90 trading days
Powered by Morningstar ®
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| 101st | Artrya | 141% |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | Artrya | $3.7m |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Company Activity
| RANKING: 21 Up from 22 in Technology Companies list | 19 Feb 2024 |
| RANKING: 22 Up from 23 in Technology Companies list | 13 Jun 2023 |
| NEWS: Tagged in Board Moves March 27, 2023 | 27 Mar 2023 |
| NEWS: Tagged in Artrya co-founder steps down | 27 Mar 2023 |
| NEW ROLE: Mathew Regan, Chief Executive | 27 Mar 2023 |
| NEWS: Tagged in Board Moves February 22, 2023 | 22 Feb 2023 |
| NEW ROLE: Kate Hill, Non-Executive Director | 22 Feb 2023 |
| NEWS: Tagged in Mark My Words 16 December 2022 | 16 Dec 2022 |
| NEWS: Tagged in Listing gets Artrya moving | 14 Dec 2022 |
